SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-267738
Filing Date
2023-11-01
Accepted
2023-11-01 07:51:26
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d348455d424b5.htm 424B5 348520
2 EX-FILING FEES d348455dexfilingfees.htm EX-FILING FEES 23610
3 GRAPHIC g348455g45q45.jpg GRAPHIC 31177
  Complete submission text file 0001193125-23-267738.txt   412125
Mailing Address 100 FIFTH AVENUE WALTHAM MA 02451
Business Address 100 FIFTH AVENUE WALTHAM MA 02451 617-977-5700
Apellis Pharmaceuticals, Inc. (Filer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-269899 | Film No.: 231366600
SIC: 2834 Pharmaceutical Preparations